PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 135 filers reported holding PROVENTION BIO INC in Q4 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,312,743 | +131.2% | 178,952 | +1.4% | 0.00% | 0.0% |
| Q4 2022 | $1,865,224 | +151.0% | 176,464 | +6.9% | 0.00% | – |
| Q3 2022 | $743,000 | +28.8% | 165,106 | +14.7% | 0.00% | – |
| Q2 2022 | $577,000 | -46.1% | 144,008 | -1.4% | 0.00% | – |
| Q1 2022 | $1,070,000 | +32.6% | 146,063 | +1.8% | 0.00% | – |
| Q4 2021 | $807,000 | -8.9% | 143,526 | +3.7% | 0.00% | – |
| Q3 2021 | $886,000 | -72.0% | 138,358 | -63.1% | 0.00% | -100.0% |
| Q2 2021 | $3,161,000 | -17.3% | 374,954 | +3.0% | 0.00% | 0.0% |
| Q1 2021 | $3,821,000 | -28.8% | 364,029 | +14.9% | 0.00% | -50.0% |
| Q4 2020 | $5,367,000 | +33.0% | 316,796 | +0.7% | 0.00% | 0.0% |
| Q3 2020 | $4,036,000 | +179.7% | 314,540 | +207.7% | 0.00% | +100.0% |
| Q2 2020 | $1,443,000 | +976.9% | 102,220 | +602.4% | 0.00% | – |
| Q1 2020 | $134,000 | -38.2% | 14,553 | 0.0% | 0.00% | – |
| Q4 2019 | $217,000 | – | 14,553 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 886,662 | $15,020,000 | 3.18% |
| Perceptive Advisors | 4,224,389 | $71,561,000 | 0.77% |
| 683 Capital Management, LLC | 859,314 | $14,557,000 | 0.69% |
| Soleus Capital Management, L.P. | 105,941 | $1,795,000 | 0.24% |
| GILDER GAGNON HOWE & CO LLC | 2,359,682 | $39,973,000 | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 247,116 | $4,186,000 | 0.15% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 23,127 | $392,000 | 0.12% |
| Virtus ETF Advisers LLC | 15,878 | $269,000 | 0.11% |
| Newbridge Financial Services Group, Inc. | 6,500 | $110,000 | 0.09% |
| Windsor Creek Advisors, LLC | 18,000 | $305,000 | 0.08% |